May 22, 2014 | Recognition of young researcher
Markus Aswendt receives DFG grant for molecular imaging of neural stem cell fate
The German Science Foundation (DFG) approved a 3 year funding of a unique approach: the non-invasive targeting of neural stem cell fate by optical imaging. Specific fluorescence and bioluminescence imaging reporters will be used to discriminate undifferentiated from differentiated cells in vivo. Markus Aswendt is working as a postdoctoral fellow in the In-vivo-NMR group of Prof. Mathias Hoehn and gets the chance to pursue independent research building on experiments during his PhD. This project will combine with high-field magnetic resonance imaging expertise to provide structural and functional tracking of the in vivo stem cell fate – an essential step towards stem cell therapy.
Mar 18, 2014 | Recognition of young researchers
And the winners are...
The institute congratulates both post docs Joanna Adamczak und Markus Aswendt of the In-vivo-NMR research group (head: Mathias Hoehn): In a multi-stage selection process they have been awarded the opportunity to attend this year’s Lindau Nobel Laureate Meeting. The 64th Lindau Meeting will take place end of June and is dedicated to physiological and medical topics. Thirty-seven Nobel Laureates are expected to meet with around 600 young researchers from 80 nations to share their knowledge, discuss new findings and to establish new contacts. Congratulations!
more on the Lindau Meeting
Oct 25, 2013 | Visiting Professorship
Intensified cooperation: Stem cell therapy and molecular imaging
Mathias Hoehn, Head of the In-vivo-NMR Laboratory at the Max Planck Institute for Neurological Research, has been appointed Visiting Professor at the University of Leiden.
Jan 09, 2013 | Career
International call for a new Independent Research Group
Interested researchers can apply until Jan 30 by proposing their research project. The group will be implemented in collaboration with the Medical Faculty of the University Cologne and be based at the MPI for Neurological Research.